These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 18762405)

  • 1. The information needed by Canadian early-stage prostate cancer patients for decision-making: stable over a decade.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD
    Patient Educ Couns; 2008 Dec; 73(3):437-42. PubMed ID: 18762405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall information needs of early-stage prostate cancer patients over a decade: highly variable and remarkably stable.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD; Siemens DR
    Support Care Cancer; 2009 Apr; 17(4):429-35. PubMed ID: 18830718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Information priorities of Italian early-stage prostate cancer patients and of their health-care professionals.
    Capirci C; Feldman-Stewart D; Mandoliti G; Brundage M; Belluco G; Magnani K
    Patient Educ Couns; 2005 Feb; 56(2):174-81. PubMed ID: 15653246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
    Feldman-Stewart D; Madarnas Y; Mates M; Tong C; Grunfeld E; Verma S; Carolan H; Brundage M
    Patient Educ Couns; 2013 Oct; 93(1):114-21. PubMed ID: 23747087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A purpose-based evaluation of information for patients: an approach to measuring effectiveness.
    Feldman-Stewart D; Brennenstuhl S; Brundage MD
    Patient Educ Couns; 2007 Mar; 65(3):311-9. PubMed ID: 17014979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapy.
    Feldman-Stewart D; Madarnas Y; Mates M; Tong C; Grunfeld E; Verma S; Carolan H; Brundage M
    Breast; 2013 Oct; 22(5):919-25. PubMed ID: 23721853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Information and decision-making preferences of men with prostate cancer.
    Davison BJ; Degner LF; Morgan TR
    Oncol Nurs Forum; 1995 Oct; 22(9):1401-8. PubMed ID: 8539181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Men considering a hypothetical treatment for prostate cancer: a comparison to patients.
    Van Manen L; Feldman-Stewart D; Brundage MD
    Patient Educ Couns; 2006 Apr; 61(1):33-42. PubMed ID: 16257170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
    Davison BJ; Goldenberg SL; Gleave ME; Degner LF
    Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unwanted control: how patients in the primary care setting decide about screening for prostate cancer.
    Woolf SH; Krist AH; Johnson RE; Stenborg PS
    Patient Educ Couns; 2005 Jan; 56(1):116-24. PubMed ID: 15590232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incomplete and inconsistent information provided to men making decisions for treatment of early-stage prostate cancer.
    Snow SL; Panton RL; Butler LJ; Wilke DR; Rutledge RD; Bell DG; Rendon RA
    Urology; 2007 May; 69(5):941-5. PubMed ID: 17482939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence-based patient choice: a prostate cancer decision aid in plain language.
    Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
    BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating a decision aid for patients with localized prostate cancer in clinical practice.
    Isebaert S; Van Audenhove C; Haustermans K; Junius S; Joniau S; De Ridder K; Van Poppel H
    Urol Int; 2008; 81(4):383-8. PubMed ID: 19077396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of factors influencing the participation of patients with prostate cancer in clinical trials: a Canadian perspective.
    Davison BJ; So A; Goldenberg SL; Berkowitz J; Gleave ME
    BJU Int; 2008 Apr; 101(8):982-7. PubMed ID: 18005198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer treatment decisions: a focus group exploration.
    O'Rourke ME; Germino BB
    Oncol Nurs Forum; 1998; 25(1):97-104. PubMed ID: 9460777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared decision making in patients with newly diagnosed prostate cancer: a model for treatment education and support.
    Colella KM; DeLuca G
    Urol Nurs; 2004 Jun; 24(3):187-91, 195-6. PubMed ID: 15311487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing a generic and individualized information decision support intervention for men newly diagnosed with localized prostate cancer.
    Davison BJ; Goldenberg SL; Wiens KP; Gleave ME
    Cancer Nurs; 2007; 30(5):E7-15. PubMed ID: 17876177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the black box of a decision aid: what information do patients select from an interactive Cd-Rom on treatment options in breast cancer?
    Molenaar S; Sprangers M; Oort F; Rutgers E; Luiten E; Mulder J; van Meeteren M; de Haes H
    Patient Educ Couns; 2007 Jan; 65(1):122-30. PubMed ID: 16945498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparatory education for informed decision-making in prostate cancer early detection and treatment.
    Myers RE; Kunkel EJ
    Semin Urol Oncol; 2000 Aug; 18(3):172-7. PubMed ID: 10975487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choose wisely: therapeutic decisions and quality of life in patients with prostate cancer.
    O'Rourke ME
    Clin J Oncol Nurs; 2007 Jun; 11(3):401-8. PubMed ID: 17623624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.